Resuscitation Devices Market Size and Share
Resuscitation Devices Market Analysis by Mordor Intelligence
The Resuscitation Devices Market size is estimated at USD 6.02 billion in 2025, and is expected to reach USD 7.99 billion by 2030, at a CAGR of 5.84% during the forecast period (2025-2030).
Growing cardiopulmonary disease prevalence, government-backed public-access defibrillation programs, and rapid adoption of AI-integrated airway and defibrillation systems underpin this steady expansion. North America’s mature reimbursement ecosystem, mandatory AED deployment in transportation hubs, and federal funding for emergency medical services sustain premium device demand. Meanwhile, Asia-Pacific’s 9.13% CAGR reflects supportive industrial policies, ISO regulatory alignment, and extensive public-private investment in indigenous manufacturing capacity. On the product front, single-use airway management devices gain traction as infection-control imperatives remain top of mind, and AI-enabled wearable cardioverter defibrillators open home-care revenue streams. Competitive dynamics feature moderate fragmentation, with leading firms divesting non-core assets and acquiring niche technologies to sharpen clinical relevance and expand connected-care portfolios.
Key Report Takeaways
- By product type, airway management devices captured 41.33% of resuscitation devices market share in 2024, while wearable cardioverter defibrillators are forecast to expand at a 10.17% CAGR to 2030.
- By patient type, adult patients held 65.19% of the resuscitation devices market size in 2024; neonatal applications are advancing at an 8.25% CAGR through 2030.
- By end user, hospitals dominated with 56.94% revenue share in 2024, whereas home care is projected to grow at a 7.69% CAGR over the same period.
- By geography, North America led with 37.43% share of the resuscitation devices market in 2024, while Asia-Pacific records the fastest regional CAGR at 9.13% through 2030.
Global Resuscitation Devices Market Trends and Insights
Drivers Impact Analysis
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Escalating global cardiopulmonary disease burden | +1.2% | North America, Europe, global | Long term (≥4 years) |
Rising demand for pre-hospital emergency response systems | +0.9% | Global cities | Medium term (2-4 years) |
AI-enabled monitoring & decision-support integration | +0.8% | Developed markets worldwide | Medium term (2-4 years) |
Disposable airway products for infection-control mandates | +0.6% | Global | Short term (≤2 years) |
Government mandates for public-access AEDs in transit hubs | +0.5% | North America, Europe, Asia-Pacific | Short term (≤2 years) |
Cloud-connected device-fleet management and analytics | +0.4% | Global developed economies | Long term (≥4 years) |
Source: Mordor Intelligence
Escalating Global Cardiopulmonary Disease Burden
Sudden cardiac arrest causes 180,000–300,000 deaths annually in the United States, intensifying pressure on emergency medical services.[1]Centers for Disease Control and Prevention, “Heart Disease Facts,” cdc.gov High-performing agencies that combine simulation-based CPR training with mechanical chest compression devices report markedly better outcomes, prompting wider adoption of automated solutions. Chronic cardiovascular conditions are rising: 34.4% of STEMI survivors develop heart failure within two months, lifting post-acute care costs by 31%.[2]ZOLL Medical Corporation, “Heart Failure Economic Burden Report,” zoll.com Aging demographics magnify equipment needs, and mechanical CPR platforms such as LUCAS continue to penetrate despite mixed data on manual CPR superiority. Health systems view early resuscitation as a hedge against long-term expenditure, accelerating placement of connected defibrillators across community settings.
Rising Demand for Pre-Hospital Emergency Response Systems
Reducing mechanical CPR device setup time below 395.5 seconds improves return-of-spontaneous-circulation rates, underscoring the role of rapid-deployment technologies in ambulances and first-responder kits.[3]BMC Emergency Medicine, “Mechanical CPR Setup Time Study,” biomedcentral.com Pilot programs in North Carolina demonstrate that integrating drone-delivered AEDs with EMS fleets shortens arrival intervals to 4.8 minutes and expands 5-minute coverage to 56.3% of the population. Because survival likelihood declines 10% per minute without defibrillation, municipalities increasingly endorse distributed response architectures, particularly in rural zones where travel delays are common. AI-based dispatch platforms in Copenhagen further optimize ambulance routing, revealing how big-data analytics can lift survival metrics without adding vehicles. Together, these advances re-frame pre-hospital intervention as an interconnected, data-driven ecosystem.
AI-Enabled Monitoring & Decision-Support Integration
Convolutional neural networks now achieve more than 90% accuracy in identifying traumatic injuries on the scene, enabling earlier triage decisions. Machine-learning rhythm analysis within AEDs automates shock delivery, easing the psychological load on lay rescuers while maintaining clinical precision. Smart ventilators personalize settings through continuous physiologic feedback, enhancing critical-care outcomes. Researchers are exploring symptom-forecasting models that detect dyspnea and chest pain minutes before arrest, shifting practice toward “near-term prevention” instead of post-event resuscitation. Nevertheless, widespread adoption hinges on data-privacy safeguards, clinician training, and rigorous prospective validation.
Disposable Airway Products for Infection-Control Mandates
Single-use resuscitation products became standard after COVID-19, driven by cross-contamination concerns and simplified logistics. Healthcare providers find that eliminating sterilization workflows lowers operating costs and reduces device downtime. Ambu’s SPUR II exemplifies market demand for PVC-free, DEHP-free designs that still deliver 100% FiO₂ and better tactile feedback. Disposable adoption also levels the playing field for facilities lacking sophisticated reprocessing units, promoting equitable access to quality care. Sustainability questions persist, but advances in plant-based polymers and recycling schemes aim to reconcile infection control with environmental stewardship.
Restraints Impact Analysis
Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Neonatal device-related barotrauma and lung injury | -0.3% | Global, emerging economies | Medium term (2-4 years) |
Burdensome product-recall & post-market surveillance costs | -0.4% | North America, Europe | Long term (≥4 years) |
Cybersecurity risks in connected defibrillators | -0.2% | Worldwide connected device users | Short term (≤2 years) |
Rare-earth magnet supply volatility for capacitor modules | -0.3% | Asia-Pacific supply chains | Medium term (2-4 years) |
Source: Mordor Intelligence
Neonatal Device-Related Barotrauma and Lung Injury
Ventilator-associated lung damage remains a central concern in newborn resuscitation, prompting recommendations to initiate with 21% oxygen rather than 100% to curb oxidative stress. Interface choice also matters: nasal masks cut injury incidence to 31.64% versus 51.67% for nasal prongs during CPAP. High-altitude regions still report mortality exceeding 60 per 1,000 live births, reflecting equipment shortages and limited training. The resulting caution dampens device utilization, and clinicians increasingly explore non-contact monitoring to mitigate mechanical trauma.
Burdensome Product-Recall & Post-Market Surveillance Costs
FDA’s move toward active post-market surveillance requires cloud-ready data pipelines and real-world evidence collection, elevating compliance costs particularly for smaller manufacturers. FY 2025 establishment registration fees climbed to USD 9,280, while 510(k) submissions rose to USD 24,335, straining cash flow for early-stage firms. Workforce reductions inside FDA may lengthen review cycles and impose stricter dossier demands. The Max Mobility SmartDrive recall illustrates how even sub-1,000-unit events can be financially disruptive when remote monitoring updates, replacement logistics, and reporting obligations are tallied. Such economics can accelerate consolidation, concentrating innovation inside capital-rich incumbents.
Segment Analysis
By Product Type: Airway Management Dominance Amid Wearable Innovation
Airway management devices held 41.33% of resuscitation devices market share in 2024, anchored by the clinical indispensability of extraglottic airways and improved disposable bag-valve-mask technology. The segment’s forecast expansion relies on ergonomic designs that cut intubation time and AI-guided ventilator settings personalized to patient physiology. Endotracheal tubes retain primacy under complex trauma but share protocols increasingly with i-gel and laryngeal masks for rapid deployment scenarios. External defibrillators form the second-largest cluster, with the wearable cardioverter subcategory posting a 10.17% CAGR as AI analytics allow real-time rhythm surveillance during everyday activities. Convective warming blankets continue to prove superior to resistive pads in preventing hypothermia during trauma resuscitation, supporting steady demand in emergency departments.
Across these offerings, the resuscitation devices market size for airway solutions is projected to rise at a mid-single-digit CAGR in line with procedure volumes and infection-control policies. Continuous material science improvements, such as PVC-free and phthalate-free polymers, enhance product safety and win institutional tenders. Meanwhile, fully automated public-access AEDs reduce user hesitation through voice prompts and shock authorization algorithms, accelerating placements in airports and shopping centers.
Note: Segment shares of all individual segments available upon report purchase
By Patient Type: Adult Dominance with Neonatal Growth Acceleration
Adults represent 65.19% of the resuscitation devices market size in 2024, thanks to higher cardiovascular event prevalence and stricter workplace AED mandates. Machine-learning-powered rhythm classifiers raise first-shock efficacy, while personal defibrillators like CellAED address the fact that 80% of sudden cardiac arrests occur at home. Pediatric indications stay consistent, employing age-appropriate energy settings and weight-specific airway interfaces. Geriatric considerations now influence design language, bigger screens, haptic alerts, and simplified battery swaps to accommodate declining dexterity.
Neonatal applications exhibit the fastest trajectory at 8.25% CAGR to 2030, owing to rising survival ambitions in perinatal asphyxia cases. Innovative chest-compression-plus-sustained-inflation protocols seek FDA IDE approval and could spur specialized hardware sales. Nasal masks gain ground over prongs, lowering complication rates and influencing purchasing guidelines. Non-contact optical sensors are trialed to curb skin breakdown and infection. Taken together, these advances position neonatology as an outsized value-creation arena for next-generation vendors.
By End User: Hospital Leadership Amid Home-Care Surge
Hospitals captured 56.94% share of the resuscitation devices market in 2024, leveraging comprehensive code-blue readiness mandates and multi-disciplinary trauma teams. Integration with EMR platforms and fleet dashboards supports predictive maintenance, while automated chest-compression systems safeguard CPR quality during long transports. Ambulatory surgical centers favor compact defibrillators with cloud connectivity that maximize limited storage footprints. Specialty cardiology clinics invest in AI-driven diagnostic defibrillators that sync arrhythmia data to patient portals for seamless follow-up.
Home care ranks as the fastest-growing channel at 7.69% CAGR due to aging-in-place preferences and user-friendly, app-guided devices. Cloud-native architectures slash unit costs; BioT shows that connected monitors can be produced for USD 200 instead of USD 20,000, unlocking broader consumer access. Remote device readiness checks ensure pads are within expiry and batteries topped, while tele-guidance functions coach lay responders in real time. The segment’s rise aligns with broader healthcare decentralization that prioritizes immediate, location-agnostic intervention.

Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America’s 37.43% revenue leadership in 2024 stems from robust bystander training initiatives and legally mandated AED presence in public venues. Federal grants subsidize equipment replacement every five years, fostering a vibrant aftermarket. Market incumbents such as ZOLL and Stryker introduce Wi-Fi-enabled defibrillators that transmit event data directly into quality-assurance registries, supporting continuous protocol refinement. Canada invests in provincial trauma-network upgrades, while Mexico streamlines regulatory pathways to stimulate domestic manufacturing.
Asia-Pacific is the fastest-expanding territory, posting a 9.13% CAGR supported by India’s vision to build a medical device sector by 2030. Production-Linked Incentive schemes and medical device park clusters lower entry barriers for foreign firms tapping local demand. Japan aligns its QMS with ISO 13485:2016, easing CE-to-PMDA conversions and prompting launches like Canon’s fully automatic AED that eliminates shock-decision overwhelm. China tackles low AED fluency through nationwide CPR curricula, while Australia funds rural drone-AED pilots to improve golden-minute access.
Europe maintains steady incremental growth, propelled by cross-border regulatory convergence under the Medical Device Regulation and national health systems that refresh fleets on fixed cycles. South America benefits from hospital construction booms, especially in Brazil, although currency volatility tempers import volumes. Middle East & Africa unlock opportunity through medical-tourism corridors, with Gulf Cooperation Council hospitals adopting premium connected ventilators. Globally, manufacturers diversify supply chains from China toward Vietnam and Thailand to buffer geopolitical tension, a trend mirrored in rare-earth magnet sourcing strategies.

Competitive Landscape
The resuscitation devices industry exhibits moderate fragmentation. Philips’ sale of its Emergency Care business to Bridgefield Capital illustrates a pivot toward higher-margin imaging and informatics, yet Philips retains a 15-year brand-licensing arrangement to protect installed-base loyalty. ZOLL’s purchase of Vyaire Medical’s ventilator division strengthens its respiratory continuum and fortifies cross-selling into defibrillator accounts. Drägerwerk integrates AI-enabled ventilator algorithms co-developed with university hospitals to differentiate in clinical decision support.
Medtronic’s PulseSelect pulsed-field ablation system and ultra-slim OmniaSecure lead expand its electrophysiology suite, positioning the firm for bundled arrhythmia care strategies. Stryker’s LIFEPAK 35 adds cloud log-sync and remote service diagnostics to compress field downtime. Start-ups attack white spaces: CellAED pursues consumer self-defibrillation; 410 Medical scales rapid-fluid resuscitation devices following a USD 14 million Series B; and CPR Therapeutics’ multimodal system merges hemodynamic feedback with defibrillation to optimize resuscitation.
Regulatory overhead shifts competitive calculus. Higher user fees and active-surveillance mandates advantage capital-rich incumbents over niche vendors. Supply-chain diversification also shapes strategy as capacitor-grade rare-earth magnet volatility forces procurement hedging; Neo Performance Materials reported revenue declines in Q3 2024 driven by medical-device demand weakness, signaling broader raw-material exposure. Overall, technology convergence, portfolio pruning, and manufacturing relocation define the go-forward playbook.
Resuscitation Devices Industry Leaders
-
Drägerwerk AG & Co. KGaA
-
Koninklijke Philips N.V
-
Medtronic
-
ZOLL Medical
-
Mindray Bio-Medical
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- May 2025: 410 Medical, Inc., a medical device company specializing in breakthrough technologies for emergency and critical care, has completed a USD 14 million Series B financing round. The funding was led by existing investor Hatteras Venture Partners, with strong participation from a coalition of strategic partners including Orlando Health Ventures, Ballad Ventures, OSF Healthcare, WakeMed, Rex Health Ventures, CU Healthcare Innovations Fund, and Sarnova. This capital infusion will support the company’s ongoing efforts to scale product adoption, expand clinical evidence, and drive innovation in rapid fluid resuscitation technologies.
- March 2025: CPR Therapeutics Inc., an early-stage medical device start-up backed by the NSF and NIH, has received a continuation U.S. patent (US12,285,621) for its groundbreaking multimodal cardiopulmonary resuscitation (CPR) system. The patented technology - "Automated Resuscitation System Integrating Hemodynamic and Defibrillatory Capabilities"—underpins a novel device designed for emergency use.
- January 2025: Philips announced the sale of its Emergency Care business to Bridgefield Capital, including automated external defibrillators and critical care products, with completion expected in the second half of 2025 pending regulatory approval. This strategic divestment allows Philips to focus on areas with greater financial impact while maintaining 15-year brand licensing rights
- September 2024: Medtronic launched the VitalFlow ECMO system, designed to enhance bedside care and intra-hospital transport, featuring a large touch screen for real-time data and a portable design for efficient use across hospital departments. The system stems from Medtronic's acquisition of MC3 Cardiopulmonary and addresses clinicians' needs for user-friendly ECMO solutions.
- June 2024: Stryker launched the LIFEPAK 35 monitor/defibrillator designed to reduce caregiver burden and enhance workflow for emergency responders, featuring advanced technology, real-time patient information access, and a user-friendly interface with trend monitoring capabilities.
Global Resuscitation Devices Market Report Scope
As per the scope, Resuscitation devices aim to initiate spontaneous breathing by mechanically ventilating the lungs. These devices maneuvers optimize tissue uptake of oxygen, improve oxygen delivery, and preserve the metabolic rate of oxygen. Resuscitation Devices Market is segmented By Product Type, End-User and Geography.
By Product Type | Airway Management Devices | Endotracheal Tubes | |
Tracheostomy Tubes | |||
Mechanical Ventilators | |||
Resuscitators (BVM) | |||
Others | |||
External Defibrillators | Fully Automated AEDs | ||
Semi-Automated AEDs | |||
Wearable Cardioverter Defibrillators | |||
Convective Warming Blankets | |||
By Patient Type | Adult | ||
Pediatric | |||
Neonatal | |||
By End User | Hospitals | ||
Ambulatory Surgical & Emergency Centers | |||
Speciality Clinics | |||
Home Care Settings | |||
By Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East & Africa | GCC | ||
South Africa | |||
Rest of Middle East & Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Airway Management Devices | Endotracheal Tubes |
Tracheostomy Tubes | |
Mechanical Ventilators | |
Resuscitators (BVM) | |
Others | |
External Defibrillators | Fully Automated AEDs |
Semi-Automated AEDs | |
Wearable Cardioverter Defibrillators | |
Convective Warming Blankets |
Adult |
Pediatric |
Neonatal |
Hospitals |
Ambulatory Surgical & Emergency Centers |
Speciality Clinics |
Home Care Settings |
North America | United States |
Canada | |
Mexico | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South Korea | |
Rest of Asia-Pacific | |
Middle East & Africa | GCC |
South Africa | |
Rest of Middle East & Africa | |
South America | Brazil |
Argentina | |
Rest of South America |
Key Questions Answered in the Report
What is the current value of the resuscitation devices market?
The resuscitation devices market is worth USD 6.02 billion in 2025 and is forecast to reach USD 7.99 billion by 2030, growing at a 5.84% CAGR.
Which segment holds the largest share of the market?
Airway management devices lead with 41.33% resuscitation devices market share in 2024 due to their indispensability in emergency protocols.
Which region is growing the fastest?
Asia-Pacific records the highest regional CAGR at 9.13% through 2030, supported by industrial incentives in India and regulatory alignment in Japan.
Why are wearable cardioverter defibrillators gaining popularity?
Wearable cardioverter defibrillators are expanding at a 10.17% CAGR because AI-enabled monitoring allows continuous rhythm analysis, particularly valuable in home-care settings.
How are infection-control policies shaping product design?
Post-COVID guidelines have accelerated adoption of single-use airway devices, prompting manufacturers to develop PVC-free disposable resuscitators that minimize cross-contamination.
What challenges do manufacturers face with connected devices?
Cybersecurity threats and heightened post-market surveillance obligations increase compliance costs and necessitate robust software patch management across connected defibrillator fleets.
Page last updated on: June 23, 2025